Sponsor or institution

Clinical trials and research at Avalyn Pharma Inc.

• 2Clinical trials
• 14Countries

All recruiting trials (2)

• AP02 (inhaled nintedanib) for idiopathic pulmonary fibrosis

  This trial will test whether inhaled nintedanib (AP02), given twice daily at two different doses, improves lung function and fibrosis measures in adults 40 and older with idiopathic pulmonary fibrosis compared with placebo.

  Recruiting at 49 sites Phase 2 Avalyn Pharma Inc. · Camperdown, New South Wales and 48 other locations · NCT07194382

• Extension of inhaled antifibrotic treatment with AP01 for pulmonary fibrosis

  This open-label extension lets people with progressive pulmonary fibrosis or IPF who finished a prior Avalyn inhaled-drug study continue taking inhaled pirfenidone (AP01) twice daily to see if they can tolerate and stay on treatment.

  Recruiting at 88 sites Phase 2 Avalyn Pharma Inc. · Birmingham, Alabama and 91 other locations · NCT06951217

Quick answers

How many clinical trials run by Avalyn Pharma Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in Australia (2 trials), Canada (2 trials), Germany (2 trials), New Zealand (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →